Lv3
350 积分 2022-06-15 加入
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
15小时前
已完结
Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
15小时前
已完结
A PARP1-TIMELESS alliance in cancer therapy
2个月前
已完结
DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumors
2个月前
已完结
Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation
2个月前
已关闭
The antibody–drug conjugate landscape
3个月前
已完结
MUC1: An emerging target in cancer treatment and diagnosis
3个月前
已完结
Synthesis and Structure-Activity Optimization of Azepane-Containing Derivatives as PTPN2/PTPN1 Inhibitors
4个月前
已完结
Cancer therapy with antibodies
5个月前
已完结
The irreversible FGFR inhibitor KIN-3248 overcomes FGFR2 kinase domain mutations
7个月前
已完结
Research Letter: TBI Severity Moderates the Association Between Subjective and Objective Attention in Older Veterans
皖公网安备34019202002308
